-
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy
Korst, C. L. B. M., Tahri, S., Duetz, C., Bruins, W. S. C., de Jonge, A. V., de Jong, M. E., Fokkema, C., Smits, F., Groen, K., Verkleij, C. P. M., Frerichs, K. A., Papazian, N., van Duin, M., van Beek, G., Hoogenboezem, R., Baardemans, T., Dal Collo, G., Stoetman, E. C. G., Cosovic, M. & Twickler, I. & 15 others, , 19 Jun 2025, In: Blood. 145, 25, p. 3007-3014 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Response to DA-EPOCH-R is associated with activation of 'fitter' cytotoxic T cells in patients with newly diagnosed double and triple hit high-grade B-cell lymphoma
de Jonge, A. V., Bruins, W. S. C., Duetz, C., Korst, C. L. B. M., Rentenaar, R., Cosovic, M., Eken, M., Kersten, M.-J., Sandberg, Y., van Rijn, R. S., Fijnheer, R., Mutsaers, P., Vergote, V. K. J., Issa, D., Beeker, A., Bilgin, Y. M., Visser, O., van Werkhoven, E., Roemer, M. G. M. & Chamuleau, M. E. D. & 1 others, , 1 Nov 2024, In: Haematologica. 109, 11, p. 3760-3761 2 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma
Korst, C. L. B. M., O'Neill, C., Bruins, W. S. C., Cosovic, M., Twickler, I., Verkleij, C. P. M., le Clerre, D., Themeli, M., Chion-Sotinel, I., Zweegman, S., Galetto, R., Mutis, T. & van de Donk, N. W. C. J., 25 Jul 2024, In: Journal for Immunotherapy of Cancer. 12, 7, e008769.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
